Singapore markets open in 38 minutes

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
17.000-0.160 (-0.93%)
At close: 04:08PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 43.91B
Enterprise value 31.00B
Trailing P/E 6.43
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.35
Price/book (mrq)0.80
Enterprise value/revenue 0.44
Enterprise value/EBITDA 5.53

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 3-14.20%
S&P500 52-week change 3-14.01%
52-week high 324.000
52-week low 316.560
50-day moving average 319.001
200-day moving average 320.527

Share statistics

Avg vol (3-month) 3454.39k
Avg vol (10-day) 3381.58k
Shares outstanding 5219.9M
Implied shares outstanding 6N/A
Float 8837.93M
% held by insiders 10.00%
% held by institutions 134.41%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.81
Forward annual dividend yield 44.69%
Trailing annual dividend rate 30.69
Trailing annual dividend yield 34.00%
5-year average dividend yield 42.38
Payout ratio 429.36%
Dividend date 3N/A
Ex-dividend date 410 Jun 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022


Profit margin 5.43%
Operating margin (ttm)5.80%

Management effectiveness

Return on assets (ttm)3.93%
Return on equity (ttm)12.93%

Income statement

Revenue (ttm)70.11B
Revenue per share (ttm)43.12
Quarterly revenue growth (yoy)3.70%
Gross profit (ttm)13.19B
Net income avi to common (ttm)3.81B
Diluted EPS (ttm)2.580
Quarterly earnings growth (yoy)-10.40%

Balance sheet

Total cash (mrq)22.6B
Total cash per share (mrq)13.9
Total debt (mrq)10.9B
Total debt/equity (mrq)33.07
Current ratio (mrq)1.71
Book value per share (mrq)18.78

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A